Yaegashi, Hiroko http://orcid.org/0000-0003-1806-5980
Hayashi, Yukikazu
Takeda, Makoto
Chiu, Shih-Wei
Nakayama, Haruhiko
Ito, Hiroyuki
Takano, Atsushi
Tsuboi, Masahiro
Teramoto, Koji
Suzuki, Hiroyuki
Kato, Tatsuya
Yasui, Hiroshi
Nagamura, Fumitaka
Daigo, Yataro
Yamaguchi, Takuhiro
Article History
Received: 2 November 2023
Accepted: 12 May 2024
First Online: 2 July 2024
Declarations
:
: MT received grants from MSD, AstraZeneca KK, Bristol–Myers Squibb KK, Ono Pharmaceutical Co., LTD, Eli Lilly Japan, Novartis, and MiRXES; and honoraria for lectures from Johnson & Johnson Japan, Medtronic Japan, AstraZeneca KK, Eli Lilly Japan, Chugai Pharmaceutical Co., LTD, Taiho Pharma, Bristol–Myers Squibb KK, Ono Pharmaceutical Co., LTD, Novalis, MSD, and Daiichi-Sankyo; is a board member of Data Safety Monitoring Board of Chugai Pharmaceutical Co., LTD; is a board member of Advisory Board of AstraZeneca KK, MSD, Novartis, MiRXES; and is a board of directors of Japan Lung Cancer Society. FN participated on a Data Saety Monitoring Board or Advisory Board of Yakult and is a board member of Ethical Review Board, DeNA Life Science. TY reports grants from AC Medical Inc., A2 Healthcare Corporation, ClinChoice, Japan Tobacco Inc., Japan Media Corporation, Medidata Solutions, Inc., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Tsumura & Co., Daiichi-Sankyo Company, Limited., Otsuka Pharmaceutical Co., Ltd., Eisai Co., Ltd., Solasia Pharma KK, Asahi Intecc Co., Ltd., 3H Clinical Trial Inc., Medrio, Inc., Nipro Corporation, Intellim Corporation, Welby Inc., 3H Medi Solution Inc., Baseconnect Inc., Nobori Ltd., Puravida Technologies Llc., Hemp Kitchen Inc.; and consulting fees from Public Health Research Foundation, EPS Corporation, Japan Tobacco Inc., Medidata Solutions, Inc., Ono Pharmaceutical Co., Ltd., Kowa Company, Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Company, Limited., Eisai Co., Ltd., 3H Clinical Trial Inc., Intellim Corporation, AstraZeneca, Sonire Therapeutics Inc., Seikagaku Corporation, Merck & Co., Inc., Mebix, Inc., Nippon Boehringer Ingelheim Co., Ltd.; and is a board member of Incyte Biosciences Japan. The other authors declare that they have no conflicts of interest to disclose.